Thermo Fisher Scientific (TMO) Retained Earnings (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Retained Earnings for 18 consecutive years, with $62.2 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Retained Earnings rose 11.26% year-over-year to $62.2 billion; the trailing twelve-month figure through Jun 2026 stood at $62.2 billion (up 11.26% YoY), and the FY2025 full-year result was $59.2 billion, up 11.4% from the prior year.
• Retained Earnings rose to $62.2 billion in Q2 2026 per TMO's latest filing, from $60.6 billion in the prior quarter.
• Across five years, Retained Earnings topped out at $62.2 billion in Q2 2026 and bottomed at $37.5 billion in Q2 2022.
• Historically, Retained Earnings has averaged $49.6 billion across 5 years, with a median of $49.2 billion in 2024.
• The sharpest annual moves came in 2022 and 2026: Retained Earnings climbed 23.65% in 2022, then advanced 11.26% in 2026.
• Over 5 years, Retained Earnings stood at $41.9 billion in 2022, then advanced by 13.01% to $47.4 billion in 2023, then advanced by 12.11% to $53.1 billion in 2024, then gained by 11.4% to $59.2 billion in 2025, then grew by 5.14% to $62.2 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $62.2 billion, $60.6 billion, and $59.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.